Literature DB >> 24751299

The effects of mental state on assessment of bipolar temperament.

Hajime Baba1, Kentaro Kohno2, Takeshi Inoue3, Yukiei Nakai3, Atsuhito Toyomaki3, Toshihito Suzuki1, Koji Hatano2, Heii Arai1, Takeshi Terao4.   

Abstract

BACKGROUND: Although the Temperament Evaluation of Memphis, Pisa, Paris and San Diego-auto questionnaire (TEMPS-A) was designed to identify temperaments which derive from traits but not states, there is a possibility that TEMPS-A scores might be affected by mental state in non-clinical populations. For the purpose of clarifying the effects of mental state on TEMPS-A scores, it is worthwhile to examine associations of the full version of the TEMPS-A with various depressive scales and, if possible, mania rating scales.
METHODS: TEMPS-A data acquired from 314 medical students and staff was used to investigate the association of temperament scores with mental assessment scores such as the Beck Depression Inventory (BDI), the Quick Inventory of Depressive Symptomatology Self-Report Japanese version (QIDS-SR-J), the Patient Health Questionnaire-9 (PHQ-9), the Hamilton Depression rating scale (HAM-D) and the Young Mania Rating Scale (YMRS).
RESULTS: Depressive state scores were significantly and positively associated with depressive, anxious, cyclothymic, and irritable temperament scores of TEMPS-A whereas sub-threshold hypomanic state scores were significantly and positively associated with irritable temperament of TEMPS-A. There was no association between depressive state or sub-threshold hypomanic state and hyperthymic temperament scores. LIMITATIONS: The nature of the present study is cross-sectional, and it is unknown whether depressive and/or sub-threshold hypomanic states may have affected temperament scores or whether temperament scores might have affected depressive and/or sub-threshold hypomanic scores. Other limitations are that the sample may not represent the entire population and that there is no evidence that Japanese findings can be applicable outside Japan.
CONCLUSIONS: It is worthwhile to consider the effects of mental state on temperament scores of TEMPS-A even in non-clinical population.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depressive state; Hypomanic state; Mental state; TEMPS-A

Mesh:

Year:  2014        PMID: 24751299     DOI: 10.1016/j.jad.2014.03.004

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  Does Subjective Cognitive Function Mediate the Effect of Affective Temperaments on Functional Disability in Japanese Adults?

Authors:  Kuniyoshi Toyoshima; Takeshi Inoue; Jiro Masuya; Yota Fujimura; Shinji Higashi; Ichiro Kusumi
Journal:  Neuropsychiatr Dis Treat       Date:  2020-07-08       Impact factor: 2.570

2.  Relationships between temperaments, occupational stress, and insomnia among Japanese workers.

Authors:  Yasuhiko Deguchi; Shinichi Iwasaki; Hideyuki Ishimoto; Koichiro Ogawa; Yuichi Fukuda; Tomoko Nitta; Tomoe Mitake; Yukako Nogi; Koki Inoue
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

3.  Utility of TEMPS-A in differentiation between major depressive disorder, bipolar I disorder, and bipolar II disorder.

Authors:  Chihiro Morishita; Rie Kameyama; Hiroyuki Toda; Jiro Masuya; Masahiko Ichiki; Ichiro Kusumi; Takeshi Inoue
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240

4.  Relationships of affective temperament ratings to diagnosis and morbidity measures in major affective disorders.

Authors:  Alessandro Miola; Ross J Baldessarini; Marco Pinna; Leonardo Tondo
Journal:  Eur Psychiatry       Date:  2021-11-23       Impact factor: 5.361

5.  The Usefulness of Assessing and Identifying Workers' Temperaments and Their Effects on Occupational Stress in the Workplace.

Authors:  Yasuhiko Deguchi; Shinichi Iwasaki; Akihito Konishi; Hideyuki Ishimoto; Koichiro Ogawa; Yuichi Fukuda; Tomoko Nitta; Koki Inoue
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.